About Timesulin
Timesulin is a company based in London (United Kingdom) founded in 2010 was acquired by Bigfoot Biomedical in June 2017. The company has 1 employees as of January 31, 2022. Timesulin offers products and services including Timesulin. Timesulin operates in a competitive market with competitors including Xeris Pharmaceuticals, Pillo health, Spencer Health Solutions, Hero and Companion Medical, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Patients Pending Ltd
- Date of Incorporation 21 Sep, 2010
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
1
as on Jan 31, 2022
-
Acquired by
Bigfoot Biomedical
(Jun 08, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Timesulin
Timesulin offers a comprehensive portfolio of products and services, including Timesulin.
Provided access to private company data for investment purposes
Funding Insights of Timesulin
Detailed funding history for Timesulin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Timesulin
Timesulin has secured backing from 1 investor. Prominent investors backing the company include Bigfoot Biomedical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of a closed-loop automated insulin delivery system
|
Locked | Locked | Locked |
Investor details for Timesulin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Timesulin
Investment portfolio details for Timesulin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Timesulin
Detailed financials for Timesulin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Timesulin Comparisons
Peer comparison for Timesulin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Timesulin
Timesulin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xeris Pharmaceuticals, Pillo health, Spencer Health Solutions, Hero and Companion Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Liquid-stable injectables are developed for peptide and protein drug delivery.
|
|
| Locked | Locked | Locked |
Smart devices for medication adherence management are provided.
|
|
| Locked | Locked | Locked |
Devices and apps for medication adherence are provided.
|
|
| Locked | Locked | Locked |
Hero is focused on smart medication management solutions.
|
|
| Locked | Locked | Locked |
Smart insulin pens with Bluetooth smartphone connectivity are developed.
|
|
| Locked | Locked | Locked |
Smart devices for medication adherence and needle disposal are provided.
|
Detailed competitors of Timesulin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Timesulin
Complete news archive for Timesulin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Timesulin
Timesulin was founded in 2010.
Timesulin is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Jan 31, 2022, the latest employee count at Timesulin is 1.
Timesulin was founded in 2010 in London, United Kingdom, and operates in the medical device sector focused on diabetes management. A replacement cap compatible with major insulin pens is offered, featuring a built-in alarm to indicate time elapsed since the last injection. This device addresses concerns over missed or duplicate doses. The cap includes a non-replaceable battery designed to last 12 months.
Timesulin's top competitors include Xeris Pharmaceuticals, Spencer Health Solutions and Pillo health.
Timesulin offers Timesulin.
Timesulin has 1 investor. Key investors include Bigfoot Biomedical.